Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phase Genomics develops and commercializes ultra-long-range sequencing technologies and computational platforms for chromosome-scale genome assembly, cytogenetics, microbiome discovery, antimicrobial resistance surveillance, and functional genomics. Their proprietary proximity ligation/Hi-C technology has been recognized with industry awards for innovation in metagenomics. The company collaborates with major public health organizations to address global challenges such as antimicrobial resistance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phase Genomics.